| Date Filed | Type | Description |
| 02/01/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/28/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/03/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/22/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/03/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/02/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/22/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/27/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/16/2020 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on TheRealReal, Inc.|
Txns:
| Disposed of 881,000 shares
@ $0 |
|
| 07/02/2019 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on TheRealReal, Inc.|
Txns:
| Converted 3,699,136 shares
@ $0
Converted 1,107,412 shares
@ $0
Converted 2,060,411 shares
@ $0
Converted 895,290 shares
@ $0
Converted 327,149 shares
@ $0
Converted 213,510 shares
@ $0
Converted 7,398,272 preferred shares
@ $0
Converted 2,214,825 preferred shares
@ $0
Converted 4,120,823 preferred shares
@ $0
Converted 1,790,580 preferred shares
@ $0
Converted 654,298 preferred shares
@ $0 |
|
| 06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/12/2019 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on ARVINAS, INC.|
Txns:
| Disposed of 500,000 shares
@ $0 |
|
| 10/03/2018 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on ARVINAS INC.|
Txns:
| Converted 4,989,554 shares
@ $0
Converted 9,543,387 preferred shares
@ $0
Converted 4,462,837 preferred shares
@ $0
Converted 2,209,833 preferred shares
@ $0 |
|
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 13,730 shares
@ $11.0341, valued at
$151.5k
|
|
| 10/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/07/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/06/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2016 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 101,767 shares
@ $10.01, valued at
$1M
Sold 9,731 shares
@ $10.03, valued at
$97.6k
|
|
| 06/06/2016 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 41,193 shares
@ $10.79, valued at
$444.5k
Sold 18,428 shares
@ $10.83, valued at
$199.6k
|
|
| 06/02/2016 |
4
| Canaan IX L.P. (10% Owner) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 22,463 shares
@ $10.75, valued at
$241.5k
|
|
|